Mirae Asset Global Investments
GBIO

Mirae Asset Global Investments’s Generation Bio GBIO Stock Holding History

Mirae Asset Global Investments’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,826
Closed -$87.5K – 1919
2024
Q1 		$87.5K Buy
+1,826
New +$43K ﹤0.01% 2387
2023
Q4 		– Sell
-1,981
Closed -$75.1K – 2565
2023
Q3 		$75.1K Buy
1,981
+7
+0.4% +$331 ﹤0.01% 2515
2023
Q2 		$109K Buy
1,974
+1
+0.1% +$46 ﹤0.01% 2486
2023
Q1 		$84.8K Sell
1,973
-3
-0.2% -$145 ﹤0.01% 2468
2022
Q4 		$77.7K Buy
1,976
+3
+0.2% +$158 ﹤0.01% 2488
2022
Q3 		$105K Buy
1,973
+596
+43% +$37.3K ﹤0.01% 2494
2022
Q2 		$91K Buy
+1,377
New +$90K ﹤0.01% 2320

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Mirae Asset Global Investments's GBIO Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Generation Bio (GBIO) in Q2 2024, closing a stake of 1,826 shares — an estimated $87.5K sold.

Mirae Asset Global Investments first reported a position in GBIO in Q2 2022 and held it in 7 quarters. The position peaked at $109K in Q2 2023. 77 funds tracked by Wall St. Rank hold GBIO as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining Generation Bio position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 1,826 Generation Bio shares in Q2 2024, an estimated $87.5K.
  • Mirae Asset Global Investments first reported a position in Generation Bio in Q2 2022 and held it in 7 quarters.
  • Mirae Asset Global Investments's Generation Bio position peaked at $109K in Q2 2023.
  • 77 funds tracked by Wall St. Rank held Generation Bio as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.